The campaign aims to accelerate groundbreaking research, expand clinical trials, and bring hope to patients. ❤️ ...

MD Anderson Cancer Center has publicly launched its largest fundraising effort ever — which has already received major ...

“As a two-time prostate cancer survivor, I enjoy today as if it will be my last,” Jesse said. “I engage every man I meet ...

HOUSTON, OCTOBER 30, 2025 ― At The University of Texas MD Anderson Cancer Center , research breakthroughs are made possible through seamless ...

The Prostate Cancer Foundation (PCF) today announced the first-ever recipient of the PCF Women in Science Lifetime Achievement Award, Maha Hussain, MD, FACP, FASCO, the Genevieve Teuton Professor of ...

– Dr. Hussain was chosen for her extraordinary career in prostate cancer research, profound impact on patients, and mentorship of the next generation of prostate cancer researchers – – Award ...

Former President Joseph R. Biden Jr. began radiation therapy last month for an aggressive form of prostate cancer. It is unclear if his treatment has ended. By Yan Zhuang and Reid J. Epstein Former ...

Former President Joe Biden has completed a round of radiation therapy for an aggressive form of prostate cancer. The 82-year-old finished several weeks of therapy at Penn Medicine Radiation Oncology ...

Novartis has shared detailed data showing its radioligand therapy Pluvicto could slow the progression of certain hormone-sensitive prostate cancers ahead of a planned application with the FDA.

This story is brought to you by Ochsner Health. The partnership between Ochsner Health and MD Anderson Cancer Center continues to gain momentum. Now, more cancer patients throughout South Louisiana ...

A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 ...